Search

Your search keyword '"Linker R"' showing total 351 results
Start Over Author "Linker R"
351 results on '"Linker R"'

2. Precision drip irrigation for horticulture

Author

Ben-Gal, A., primary, Cohen, Y., additional, Peeters, A., additional, Naor, A., additional, Nezer, Y., additional, Ohana-Levi, N., additional, Bahat, I., additional, Katz, L., additional, Shaked, B., additional, Linker, R., additional, Yulzary, S., additional, and Alchanatis, V., additional

Published
2022
Full Text
View/download PDF

10. The German trial on Aciclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis (GACHE): a multicenter, randomized, double-blind, placebo-controlled trial

Author

Meyding-Lamadé, U., primary, Jacobi, C., additional, Martinez-Torres, F., additional, Lenhard, T., additional, Kress, B., additional, Kieser, M., additional, Klose, C., additional, Einhäupl, K., additional, Bösel, J., additional, Mackert, M-B, additional, Homberg, V., additional, Koennecke, C., additional, Weißheit, G., additional, Claus, D., additional, Kieseier, B., additional, Bardutzky, J., additional, Neumann-Haefelin, T., additional, Lorenz, M. W., additional, Steinmetz, H., additional, Gerloff, C., additional, Schneider, D., additional, Grau, A., additional, Klein, M., additional, Dziewas, R., additional, Bogdahn, U., additional, Jakob, W., additional, Linker, R., additional, Fuchs, K., additional, Sander, A., additional, Luntz, S., additional, Hoppe-Tichy, T., additional, Hanley, D. F., additional, von Kummer, R., additional, and Craemer, E., additional

Published
2019
Full Text
View/download PDF

16. Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in

Author

Pugliatti, M, Hartung, HP, Oreja-Guevara, C, Pozzilli, C, Airas, L, Alkhawajah, M, Grigoriadis, N, Magyari, M, VAN WIJMEERSCH, Bart, Zakaria, M, Linker, R, Chan, A, Vermersch, P, Berger, T, Pugliatti, M, Hartung, HP, Oreja-Guevara, C, Pozzilli, C, Airas, L, Alkhawajah, M, Grigoriadis, N, Magyari, M, VAN WIJMEERSCH, Bart, Zakaria, M, Linker, R, Chan, A, Vermersch, P, and Berger, T

Subjects
SARS-CoV-2, disease modifying therapies, COVID-19, vaccines, multiple sclerosis, immune response, adverse events
Abstract

It has been over a year since people with multiple sclerosis (pwMS) have been receiving vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With a negligible number of cases in which vaccination led to a relapse or new onset MS, experts around the world agree that the potential consequences of COVID-19 in pwMS by far outweigh the risks of vaccination. This article reviews the currently available types of anti-SARS-CoV-2 vaccines and the immune responses they elicit in pwMS treated with different DMTs. Findings to date highlight the importance of vaccine timing in relation to DMT dosing to maximize protection, and of encouraging pwMS to get booster doses when offered.

Published
2022

20. Monitoring von Blutparametern unter verlaufsmodifizierender MS-Therapie: Substanzspezifische Relevanz und aktuelle Handlungsempfehlungen

Author

Klotz, L., Berthele, A., Brück, W., Chan, A., Flachenecker, P., Gold, R., Haghikia, A., Hellwig, K., Hemmer, B., Hohlfeld, R., Korn, T., Kümpfel, T., Lang, M., Limmroth, V., Linker, R. A., Meier, U., Meuth, S. G., Paul, F., Salmen, A., Stangel, M., Tackenberg, B., Tumani, H., Warnke, C., Weber, M. S., Ziemssen, T., Zipp, F., and Wiendl, H.

Published
2016
Full Text
View/download PDF

21. FLAIRfusion Processing with Contrast Inversion

Author

Schmidt, M. A., primary, Linker, R. A., additional, Lang, S., additional, Lücking, H., additional, Engelhorn, T., additional, Kloska, S., additional, Uder, M., additional, Cavallaro, A., additional, Dörfler, A., additional, and Dankerl, P., additional

Published
2017
Full Text
View/download PDF

23. Operational Precise Irrigation for Cotton Cultivation through the Coupling of Meteorological and Crop Growth Models

Author

Tsakmakis, I., primary, Kokkos, N., additional, Pisinaras, V., additional, Papaevangelou, V., additional, Hatzigiannakis, E., additional, Arampatzis, G., additional, Gikas, G.D., additional, Linker, R., additional, Zoras, S., additional, Evagelopoulos, V., additional, Tsihrintzis, V.A., additional, Battilani, A., additional, and Sylaios, G., additional

Published
2016
Full Text
View/download PDF

28. 8D.05

Author

Domenig, O., primary, Manzel, A., additional, Grobe, N., additional, Kaltenecker, C., additional, Kovarik, J., additional, Stegbauer, J., additional, Gurley, S.B., additional, Antlanger, M., additional, Elased, K., additional, Saemann, M., additional, Linker, R., additional, and Poglitsch, M., additional

Published
2015
Full Text
View/download PDF

35. Real time monitoring of N 2 O emissions from agricultural soils using FTIR spectroscopy

Author

Dubowski, Y., Harush, D., Shaviv, A., Stone, L., and Linker, R.

Subjects
Environmental aspects, Research, Nitrous oxide -- Environmental aspects, Greenhouse gases -- Environmental aspects, Fourier analysis -- Research, Acetylene -- Environmental aspects
Abstract

Emissions of N2O from agricultural soils are an important source for this greenhouse gas. The present work examines the potential of Fourier transformed infrared (FTIR) spectroscopy coupled with a long path (LP) infrared (IR) gas cell for on-line measurement of concentration and isotopic signature of N2O emitted from soils. Nitrous Oxide was spectrally monitored during incubations of soil samples in a closed system under different conditions. Its emission from a Grumosol (Vertisol) was measured in presence and absence of acetylene, with various additions of nitrate and glucose, under aerobic and anaerobic conditions, and for two soil thickness layers. For comparison N2O emissions from a Terra Rossa (Cambisol) and a Hamra (Luvisol) were measured in the presence and absence of acetylene. In an additional experimental set the isotopic signature of emitted N2O was quantified after enrichment with K15NO3. Acetylene addition led to an increase in N2O emissions in all three soils but at various extents. Under aerobic conditions, N2O emission from the Grumosol became detectable only when running the experiments with a thicker soil layer (10 mm), suggesting the existence of coupled nitrification-denitrification. Nitrate addition to soils enhanced N2O emissions especially when coupled with glucose addition. Addition of 15NO3- to the Grumosol resulted in the emission of all four N2O isotopologues: 14N2O, 15N2O, 14N15NO, and 15N14NO. The observed slight delay in appearance of the species containing 15N and the relatively lower 15N enrichment of the N2O compared with the soil nitrate, indicate isotopic fractionation during denitrification. Yet, within the accuracy of our isotopic analysis, temporal emission patterns of 14N15NO and 15N14NO were similar indicating low possibility for osite preferenceo under the specific experimental conditions.

Published
2014

36. Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)

Author

Wiendl, H., Gold, R., Berger, T., Derfuss, T., Linker, R., Mäurer, M., Aktas, O., Baum, K., Berghoff, M., Bittner, S., Chan, A., Czaplinski, A., Deisenhammer, F., Di Pauli, F., Du Pasquier, R., Enzinger, C., Fertl, E., Gass, A., Gehring, K., Gobbi, C., Goebels, N., Guger, M., Haghikia, A., Hartung, H.P., Heidenreich, F., Hoffmann, O., Kallmann, B., Kleinschnitz, C., Klotz, L., Leussink, V.I., Leutmezer, F., Limmroth, V., Lünemann, J.D., Lutterotti, A., Meuth, S.G., Meyding-Lamadé, U., Platten, M., Rieckmann, P., Schmidt, S., Tumani, H., Weber, F., Weber, M.S., Zettl, U.K., Ziemssen, T., Zipp, F., and ‘Multiple Sclerosis Therapy Consensus Group' (MSTCG)

Subjects
disease-modifying therapy, guideline, multiple sclerosis, treatment recommendation
Abstract

Multiple sclerosis is a complex, autoimmune-mediated disease of the central nervous system characterized by inflammatory demyelination and axonal/neuronal damage. The approval of various disease-modifying therapies and our increased understanding of disease mechanisms and evolution in recent years have significantly changed the prognosis and course of the disease. This update of the Multiple Sclerosis Therapy Consensus Group treatment recommendation focuses on the most important recommendations for disease-modifying therapies of multiple sclerosis in 2021. Our recommendations are based on current scientific evidence and apply to those medications approved in wide parts of Europe, particularly German-speaking countries (Germany, Austria, and Switzerland).

Published
2021

41. Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage

Author

Filippi, Massimo, Rocca, Maria A, Pagani, Elisabetta, De Stefano, Nicola, Jeffery, Douglas, Kappos, Ludwig, Montalban, Xavier, Boyko, Alexei N, Comi, Giancarlo, Filippi, M, Rocca, MA, Absinta, M, Longoni, G, Galantucci, S., Pagani, E, DallʼOcchio, L., Misci, P., Petrolini, M., Sala, S., Vuotto, R., Comi, G, Boyko, A, Filippi, M, Jeffery, D, Kappos, L, Montalban, x, McFarland, H, Bauer, K, Galay, N, Weber, J, Franta, C, Lampi, C, Shotekov, P, Bozhinov, S, Deleva, N, Haralanov, L, Ivanova Hristova, S, Petrov, I, Milanov, I, Kremenchutzky, M, Rabinovitch, H, Ayotte, C, GrandMaison, F, Lamontagne, A, Leckey, R, Lee, L, Hradilek, P, Kanovsky, P, Gross-Paju, K, Taba, P, Vermersch, P, Rumbach, L, Clavelou, P, Confavreux, C, Pelletier, J, Edan, G, Shakarishvili, R, Tsiskaridze, A, Becker, E, Chan, A, Eggers, J, Haas, J, Heesen, C, Heidenreich, F, Koehler, J., Koelmel, H W, Linker, R, Oschmann, P, Rauer, S, Maschke, M, Mueller, M, Reifschneider, G, Wildemann, B, Steinbrecher, A, Tumani, H, Ziebold, U, Ziemssen, T, Kanya, J, Jakab, G, Valikovics, A, Bartos, L, Karussis, D, Rawashdeh, H, Karni, A, Chapman, J, Comi, G, Caputo, D, Centonze, D, Cottone, S, Ghezzi, A, Maimone, D, Montanari, E, Plewnia, K, Scarpini, E, Metra, M, Rastenyte, D, Sceponaviciute, S, De Jong, B, Frequin, S, Visser, L, Zwanikken, C., Selmaj, K, Blaszczyk, B., Wajgt, A, Nowak, R, Jasinska, E, Brola, W, Sobkowiak-Osinska, M, Kapustecki, J, Zaborski, J, Panea, CA, Simu, M, Bulboaca, AC, Balasa, RI, Carciumaru, N, Boyko, A, Skoromets, A, Stolyarov, I, Perfilyev, S, Odinak, M, Amelina, O, Malkova, N, Gustov, A, Volkova, L, Shutov, A, Drulovic, J, Vojinovic, S, Montalban, Arroyo, R, Saiz Hinarejos, A, Brieva, L, Ramio, L, Meca Lallana, J, Amigo Jorrin, MdC, Prieto, JM, Munoz Gracia, D, Aladro, Y, Coret, F, Escartin, A, Diez Tejedor, E, Hillert, J, Olddon, T, Martin, C, Idiman, E, Sharrack, B, Giovannoni, G, Young, C, Nehrych, T, Moskovko, S, Kobys, T, AIpatov, Loganovskyi, K, AbouZeid, N, Jeffery, D, Dihenia, B, Carpenter, A, Flitman, S, Gazda, S, Goodman, A, Green, B, Gupta, A, Herbert, J, Hughes, B, Jacobs, A, Khatri, B, Lynch, S, Miller, T, Markowitz, C, Murray, R, Pardo, G, Parry, G, Gottschalk, G, Rossman, H, Scaberry, S, Thomas, F, Turel, A, Anderson, G, CTwyman, and Wyn, D

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results